HOUSTON, Nov. 22, 2010 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of cost-effective management solutions for medical waste generated outside the hospital and large healthcare facility setting and unused dispensed medications, announced today that lead independent board member F. Gardner Parker assumed the position of non-executive Chairman of the Board of Directors on November 18, 2010. Mr. Parker succeeds Dr. Burton J. Kunik in his prior role as Chairman of the Board. Dr. Kunik founded Sharps in 1994 and retired as Chief Executive Officer on September 30, 2010 and as Chairman on November 18, 2010. Mr. Parker has been a director of Sharps since February 2003, and was named the Company's Lead Independent Director in November 2008. Mr. Parker also serves on the Audit and Corporate Governance Committees. "We are very pleased that Gardner has accepted the Chairmanship," said David P. Tusa, Chief Executive Officer and President of Sharps. "He has played an important role working with senior management to develop and execute on our growth strategy. His leadership and experience will serve us well as Sharps continues to build on what we believe is a $2 billion market opportunity." Mr. Parker commented, "I am honored to serve Sharps as its Chairman, and look forward to supporting senior management of the Company as it advances the strategic direction of the Company. Driven by Burt's entrepreneurial spirit and innovative thinking, the Company has evolved and experienced successful expansion. On behalf of the Board, I want to thank Burt for his active and engaged contribution as Chairman, and wish him well with his future endeavors." Mr. Parker currently serves on the board of directors of five other public companies, including: Camden Property Trust (NYSE:CPT), Pinnacle Oil & Gas (Nasdaq:PINN), Hercules Offshore (Nasdaq:HERO), Triangle Petroleum Corporation (Amex:TPLM), and Carrizo Oil & Gas (Nasdaq:CRZO). Mr. Parker is NACD Board Certified. He began his career with Ernst & Young where he served as a partner.